Carlos Campoy
Director/Board Member chez ZYMEWORKS INC.
Fortune : - $ au 31/03/2024
Profil
Carlos E.
Campoy is currently a Director at Zymeworks BC, Inc. and an Independent Director at Zymeworks, Inc. He previously worked as a Director at TP Orthodontics, Inc. from 2006 to 2010, Chief Financial Officer at Eli Lilly Japan KK in 2013-2014, Vice President-International Finance at Allergan Ltd.
(Ireland) from 2014 to 2016, Partner at Think Forwards in 2017-2018, and Chief Financial Officer at Lundbeck Seattle BioPharmaceuticals, Inc. from 2018 to 2019.
He also served as Chief Financial Officer & Senior Vice President at CytomX Therapeutics, Inc. from 2020 to 2022.
Mr. Campoy holds an MBA from Indiana University and an undergraduate degree from Faculdades Faccat.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZYMEWORKS INC.
-.--% | 11/10/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Carlos Campoy
| Sociétés | Poste | Début |
|---|---|---|
| ZYMEWORKS INC. | Director/Board Member | 30/06/2023 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Director/Board Member | - |
Anciens postes connus de Carlos Campoy
| Sociétés | Poste | Fin |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 30/09/2022 |
| ALDER BIOPHARMACEUTICALS, INC. | Director of Finance/CFO | 01/11/2019 |
| Think Forwards | Corporate Officer/Principal | 01/12/2018 |
| ALLERGAN PLC | Corporate Officer/Principal | 01/11/2016 |
Eli Lilly Japan KK
 Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The private company is based in Kobe, Japan. | Director of Finance/CFO | 01/07/2014 |
Formation de Carlos Campoy
| Indiana University | Masters Business Admin |
| Faculdades Faccat | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| ZYMEWORKS INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Seattle BioPharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on transforming the migraine treatment paradigm through the discovery, development and commercialization of novel therapeutic antibodies. Its product includes Eptinezumab, is an investigational monoclonal antibody (mAb) that inhibits calcitonin gene-related peptide (CGRP) and is currently in late-stage clinical development for the prevention of migraine. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. | Health Technology |
Eli Lilly Japan KK
Eli Lilly Japan KK Pharmaceuticals: MajorHealth Technology Part of Eli Lilly & Co., Eli Lilly Japan KK is a Japanese company that manufactures and trades pharmaceutical products. The private company is based in Kobe, Japan. | Health Technology |
TP Orthodontics, Inc.
 TP Orthodontics, Inc. Medical SpecialtiesHealth Technology TP Orthodontics, Inc. is a private company that manufactures and distributes orthodontic products. The company is based in La Porte, IN. The CEO of the company is Andrew C. Kesling. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
| Think Forwards |
